X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3327) 3327
Publication (572) 572
Conference Proceeding (38) 38
Book Chapter (37) 37
Book Review (33) 33
Dissertation (16) 16
Book / eBook (9) 9
Web Resource (6) 6
Magazine Article (3) 3
Streaming Video (3) 3
Government Document (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2522) 2522
index medicus (2049) 2049
animals (1948) 1948
oncolytic virotherapy (1526) 1526
oncolytic virotherapy - methods (1367) 1367
mice (1341) 1341
cancer (1217) 1217
oncology (1195) 1195
cell line, tumor (1177) 1177
medicine, research & experimental (858) 858
virotherapy (789) 789
female (788) 788
oncolytic viruses - genetics (786) 786
viruses (732) 732
biotechnology & applied microbiology (722) 722
neoplasms - therapy (718) 718
genetics & heredity (654) 654
health aspects (654) 654
tumors (624) 624
xenograft model antitumor assays (613) 613
adenoviridae - genetics (606) 606
mice, nude (587) 587
immunotherapy (585) 585
therapy (585) 585
virus replication (557) 557
care and treatment (556) 556
gene therapy (542) 542
apoptosis (507) 507
research (503) 503
oncolytic virus (484) 484
oncolytic viruses - physiology (464) 464
male (449) 449
article (429) 429
oncolysis (428) 428
adenovirus (426) 426
adenoviruses (356) 356
expression (355) 355
genetic therapy - methods (338) 338
cells (337) 337
replication (330) 330
genetic aspects (328) 328
combined modality therapy (325) 325
in-vivo (323) 323
mice, inbred balb c (323) 323
oncolytic viruses (323) 323
oncolytic adenovirus (306) 306
genetic vectors (303) 303
chemotherapy (302) 302
gene expression (302) 302
herpes-simplex-virus (299) 299
gene-therapy (287) 287
biochemistry & molecular biology (276) 276
virology (269) 269
genetic vectors - genetics (259) 259
cancer therapies (256) 256
melanoma (237) 237
genetics (235) 235
adenoviridae - physiology (231) 231
pharmacology (224) 224
genetic therapy (221) 221
molecular biology (220) 220
disease models, animal (217) 217
proteins (217) 217
molecular medicine (214) 214
treatment outcome (212) 212
cell biology (209) 209
oncolytic viruses - immunology (209) 209
neoplasms - virology (206) 206
analysis (203) 203
neoplasms - immunology (200) 200
drug discovery (199) 199
neoplasms - genetics (196) 196
original (196) 196
phase-i trial (195) 195
clinical trials (192) 192
vesicular stomatitis-virus (192) 192
brain neoplasms - therapy (187) 187
usage (187) 187
phase-i (184) 184
metastasis (183) 183
virus (181) 181
infection (180) 180
efficacy (175) 175
mice, inbred c57bl (175) 175
review (172) 172
neoplasms - pathology (168) 168
tumor cells, cultured (168) 168
vaccinia virus (164) 164
clinical trials as topic (162) 162
immunology (162) 162
infections (160) 160
cytotoxicity (157) 157
genetic engineering (157) 157
glioma - therapy (157) 157
oncolytic viruses - metabolism (157) 157
cell line (156) 156
physiological aspects (156) 156
glioma (153) 153
original article (153) 153
receptor (153) 153
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3281) 3281
Chinese (24) 24
Japanese (22) 22
German (17) 17
Russian (12) 12
French (9) 9
Spanish (5) 5
Hungarian (4) 4
Polish (3) 3
Korean (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Expert Opinion on Biological Therapy, ISSN 1471-2598, 03/2017, Volume 17, Issue 3, pp. 353 - 363
Journal Article
Cancer Research, ISSN 0008-5472, 02/2010, Volume 70, Issue 3, pp. 875 - 882
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2006, Volume 12, Issue 22, pp. 6737 - 6747
Journal Article
Nature Medicine, ISSN 1078-8956, 03/2013, Volume 19, Issue 3, pp. 329 - 336
Journal Article
Cancer Letters, ISSN 0304-3835, 2015, Volume 371, Issue 2, pp. 161 - 170
Highlights • First-in-humans, first-in-children use of MSCs as carriers for oncolytic virotherapy. • This strategy allows administering very high amount of... 
Hematology, Oncology and Palliative Medicine | Oncolytic virotherapy | Immune response | Neuroblastoma | Cell migration | Mesenchymal stem cells | MIGRATION | DENDRITIC CELLS | CHEMOKINES | BONE-MARROW | CANCER | TRIAL | GAMMA-IRRADIATION | VIROTHERAPY | ONCOLOGY | STROMAL CELLS | VIRUSES | Compassionate Use Trials | Humans | Male | Oncolytic Viruses - pathogenicity | Transplantation, Autologous | Neuroblastoma - therapy | Adenoviridae - pathogenicity | Interferon-gamma - metabolism | Mesenchymal Stem Cell Transplantation - adverse effects | Mesenchymal Stromal Cells - immunology | Neuroblastoma - secondary | Time Factors | Neuroblastoma - immunology | Female | HLA-DR Antigens - metabolism | Oncolytic Virotherapy - adverse effects | Biomarkers - metabolism | Cell Line | Mesenchymal Stromal Cells - metabolism | Treatment Outcome | Cell Adhesion | Receptors, CXCR4 - metabolism | Spain | Oncolytic Virotherapy - methods | Phenotype | Virus Replication | Receptors, Interleukin-8A - metabolism | Receptors, CCR1 - metabolism | Mesenchymal Stromal Cells - virology | Neuroblastoma - metabolism | Neuroblastoma - virology | Cell Movement | Adenoviruses | Stem cells | Metastasis | T cells | Patient outcomes | Antigens | Pediatrics | Flow cytometry | Good Manufacturing Practice | Viruses | Patients | Cell adhesion & migration | Immunotherapy | Drug dosages | Viral infections
Journal Article
BLOOD, ISSN 0006-4971, 03/2016, Volume 127, Issue 11, pp. 1449 - 1458
Patients with relapsed acute myeloid leukemia (AML) have limited therapeutic options. Vesicular stomatitis virus (VSV)-interferon beta (IFN beta-sodium iodide... 
VIROTHERAPY | CELLS | INTERFERON | MANAGEMENT | ONCOLYSIS | CTLA-4 | REOVIRUS | HEMATOLOGY | CANCER | STEM
Journal Article
Journal Article
Molecular Therapy, ISSN 1525-0016, 05/2017, Volume 25, Issue 5, pp. 1107 - 1116
Viruses can be engineered or adapted for selective propagation in neoplastic tissues and further modified for therapeutic transgene expression to enhance their... 
competitive landscape | oncolytic virotherapy | viro-immuno-oncology | T-VEC | MEDICINE, RESEARCH & EXPERIMENTAL | CLINICAL-TRIAL | MEASLES VIRUSES | INTRAVENOUS DELIVERY | OVARIAN-CANCER | CANCER-THERAPY | HERPES-SIMPLEX-VIRUS | LAHERPAREPVEC T-VEC | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | VESICULAR STOMATITIS-VIRUS | TALIMOGENE LAHERPAREPVEC | ANTITUMOR EFFICACY | Lymph Nodes - pathology | Humans | Mutant Chimeric Proteins - genetics | Plasmacytoma - genetics | Multiple Myeloma - immunology | Plasmacytoma - immunology | Plasmacytoma - pathology | Measles virus - genetics | Multiple Myeloma - therapy | Antigen Presentation | Melanoma - genetics | Mutant Chimeric Proteins - metabolism | T-Lymphocytes - pathology | Skin Neoplasms - pathology | Antigens, Neoplasm - genetics | Oncolytic Virotherapy - trends | Genetic Vectors - chemistry | Herpesvirus 1, Human - metabolism | Skin Neoplasms - immunology | Skin Neoplasms - therapy | Antigens, Neoplasm - immunology | Genetic Vectors - metabolism | Oncolytic Viruses - genetics | Lymph Nodes - immunology | Melanoma - pathology | Oncolytic Virotherapy - methods | Multiple Myeloma - pathology | Measles virus - metabolism | Melanoma - immunology | Oncolytic Viruses - immunology | Plasmacytoma - therapy | Skin Neoplasms - genetics | Herpesvirus 1, Human - genetics | T-Lymphocytes - immunology | Melanoma - therapy | Multiple Myeloma - genetics | Tumor cells | Immunomodulation | Melanoma | Antibodies | Viruses | Lymphocytes T | Kinases | Macrophages | Lymph nodes | Skin cancer | Metastases | Immune checkpoint | Immunotherapy | Antigen (tumor-associated) | Oncolysis | Review
Journal Article